Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
14 hedge funds and large institutions have $77.6K invested in Petros Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
102% more capital invested
Capital invested by funds: $38.5K → $77.6K (+$39.1K)
56% more funds holding
Funds holding: 9 → 14 (+5)
0.11% more ownership
Funds ownership: 0.04% → 0.15% (+0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$115K |
| 2 |
HF
HRT Financial
New York
|
+$28.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.7K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$18.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.7K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $38.9K | +$115K | +22,544 | New |
|
|
HF
2
HRT Financial
New York
| $9K | +$28.1K | +5,501 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $8.22K | +$21.7K | +4,243 | +816% |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $7.47K | +$14.7K | +2,880 | +199% |
|
|
XT
5
XTX Topco
George Town,
Cayman Islands
| $6.28K | +$18.6K | +3,636 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $4.24K | +$12.5K | +2,454 | New |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $2.19K | – | – | – |
|
8
BlackRock
New York
| $1.11K | – | – | – |
|
9
Morgan Stanley
New York
| $48 | +$138 | +27 | +2,700% |
|
|
SS
10
SBI Securities
Tokyo,
Japan
| $22 | +$66 | +13 | New |
|
11
National Bank of Canada
Montreal,
Quebec, Canada
| $14 | – | – | – |
|
12
Osaic Holdings
Scottsdale,
Arizona
| $14 | – | – | – |
|
13
Bank of America
Charlotte,
North Carolina
| $5 | – | – | – |
|
14
Group One Trading
Chicago,
Illinois
| $5 | – | – | – |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| $1 | – | – | – |
|
PTPI Hedge Fund Activity: Q1 2025 in Review
14 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q1 2025, worth a combined $77.6K — up 102% from $38.5K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PTPI positions and 0 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $115K.
- 14 institutional investors held Petros Pharmaceuticals (PTPI) as of Q1 2025, up from 9 in Q4 2024.
- Funds reported $77.6K of Petros Pharmaceuticals stock for Q1 2025, up 102% quarter-over-quarter.
- 5 funds opened new Petros Pharmaceuticals positions in Q1 2025 and 0 closed out, a net change of +5 holders.
- The largest Petros Pharmaceuticals buyer in Q1 2025 was Jane Street, an estimated $115K added.
Based on aggregated 13F filings for Q1 2025.